RE: News and 10p IMO14 Jun 2018 13:23
We have commercial discussion going on with potential partners,already working with Summit in China, Nuformix is targeting high-value unmet needs with its lead programmes in oncology supportive care: NXP001 and fibrosis: NXP002
We are still under the pre IPO price of 4p once the results are out it will not be long for it to be !0p IMO.